Proposed Organizational Change at NIBIB

Background

For more than 20 years, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has been transforming, through engineering, the understanding of disease and its prevention, detection, diagnosis, and treatment. In addition to its extramural research portfolio, NIBIB supports new tools and technologies to improve human health within its Intramural Research Program (IRP). As the hub of engineering at the National Institutes of Health (NIH), NIBIB proposes the establishment of a new trans-NIH Center for Biomedical Engineering and Technology Acceleration (BETA Center) to accelerate the development, validation, and dissemination of high-impact biomedical technologies to address urgent national and global health needs. The BETA Center will be housed within NIBIB's IRP and comprise researchers with specialized expertise in areas such as biomedical imaging, biosensing, engineered/synthetic biology, nano/biomaterials, artificial intelligence, modeling, computation, and informatics.

Proposed Intramural Research Program Structure

NIBIB's IRP supports laboratories and trans-NIH shared resources and plays a key role in fulfilling the Institute’s mission, particularly to advance knowledge in imaging and bioengineering research using a combination of basic, translational, and clinical science and to develop effective training programs in related fields. The BETA Center will be an additional entity housed within the IRP structure.  The diagram below illustrates the addition of the proposed BETA Center to the IRP.

 

The diagram above shows that the BETA Center falls under the Intramural Research Program, which is overseen by the Office of the Director.

Proposed BETA Center Mission

In addition to accelerating the development, validation, and dissemination of high-impact biomedical technologies, the BETA Center will serve as a new NIH campus model for accelerating technology-driven interdisciplinary research and clinical translation. Central to NIH BETA’s mission will be employing evidence-driven approaches to expand diversity, equity, and inclusion within NIBIB’s Intramural Research Program and serving as a model for recruiting diverse biomedical engineering talent to NIH.

Public Comment

The proposed reorganization is being presented to the public as required by the NIH and HHS policies on organizational changes.  Public comment will take place from June 21 and June 29, 2022. The comments will be collated and reviewed by institute staff. Comments and questions about this reorganization may be directed to NIBIBorgchange@nih.gov.